Article Versions Notes

Zwama J, Rosenberg NM, Verheij VA, Raijmakers PGHM, Yaqub M, Botman E, de Ruiter RD, Garrelfs MR, Bökenkamp A, Micha D, et al. [¹⁸F]NaF PET/CT as a Marker for Fibrodysplasia Ossificans Progressiva: From Molecular Mechanisms to Clinical Applications in Bone Disorders. Biomolecules. 2024; 14(10):1276. https://doi.org/10.3390/biom14101276

Zwama, Jolien, Neeltje M. Rosenberg, Vincent A. Verheij, Pieter G. H. M. Raijmakers, Maqsood Yaqub, Esmée Botman, Ruben D. de Ruiter, Mark R. Garrelfs, Arend Bökenkamp, Dimitra Micha, and et al. 2024. "[¹⁸F]NaF PET/CT as a Marker for Fibrodysplasia Ossificans Progressiva: From Molecular Mechanisms to Clinical Applications in Bone Disorders" Biomolecules 14, no. 10: 1276. https://doi.org/10.3390/biom14101276

Zwama, J., Rosenberg, N. M., Verheij, V. A., Raijmakers, P. G. H. M., Yaqub, M., Botman, E., de Ruiter, R. D., Garrelfs, M. R., Bökenkamp, A., Micha, D., Schwarte, L. A., Teunissen, B. P., Lammertsma, A. A., Boellaard, R., & Eekhoff, E. M. W. (2024). [¹⁸F]NaF PET/CT as a Marker for Fibrodysplasia Ossificans Progressiva: From Molecular Mechanisms to Clinical Applications in Bone Disorders. Biomolecules, 14(10), 1276. https://doi.org/10.3390/biom14101276